Showing results (331-340 of 946) with videos related to
Sort By:
Pageof 95
La Nouvelle Presse Medicale|September 26, 1981
[Clinical symptoms and anatomical locations in primary haemorrhages of the basal ganglia. A neuropathological study of 64 cases (author's transl)]P Castaigne, F Lhermitte, A Buge, et al.Brain : a Journal of Neurology|March 2, 1999
DYT1 mutation in French families with idiopathic torsion dystoniaA S Lebre, A Durr, P Jedynak, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2001
Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated miceH Turmel, A Hartmann, K Parain, et al.Synapse (New York, N.Y.)|October 23, 2001
LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian ratsC Marin, A Jiménez, M Bonastre, et al.Neuroscience Letters|March 2, 1990
Tyrosine hydroxylase-like immunoreactivity in senile plaques is not related to the density of tyrosine hydroxylase-positive fibers in patients with Alzheimer's diseaseP Cervera, C Duyckaerts, M Ruberg, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1989
Increased wave P 300 latency in progressive supranuclear palsyC Pierrot-Deseilligny, E Turell, C Penet, et al.Neuroreport|April 20, 1999
Survival factors promote BDNF protein expression in mesencephalic dopaminergic neuronsM G Murer, R Raisman-Vozari, Q Yan, et al.Biochemical and Biophysical Research Communications|April 16, 1984
Characterization and visualization of neurotensin binding to receptor sites in human brainJ L Sadoul, P Kitabgi, W Rostène, et al.Neurology|January 1, 1991
Mesencephalic cholinergic nuclei in progressive supranuclear palsyJ L Juncos, E C Hirsch, S Malessa, et al.FEBS Letters|August 29, 1994
Induction of calbindin-D 28K gene and protein expression by physiological stimuli but not in calcium-mediated degeneration in rat PC12 pheochromocytoma cellsS Vyas, P P Michel, M C Copin, et al.Pageof 95